Candong, Norhana B.

HRN: 11-30-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2025
CEFTRIAXONE 1G (VIAL)
06/27/2025
07/03/2025
IVTT
2g
Once A Day
T/C Acute Cholecystitis
Waiting Final Action 
06/27/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/27/2025
07/03/2025
IVTT
500mg
Every 8hrs
T/C Acute Cholecystitis
Waiting Final Action 
06/29/2025
AMOXICILLIN 500MG CAPSULE (CAP)
06/29/2025
07/05/2025
PO
500mg
2tabs Bid
H Pylori
Waiting Final Action 
06/29/2025
CLARITHROMYCIN 500MG (CAP)
06/29/2025
07/05/2025
PO
500mg
Bid
H Pylori
Waiting Final Action 
07/05/2025
MEBENDAZOLE 500MG (TAB)
07/05/2025
07/12/2025
TAB
500
Now
Ascariasis
Checking Initial Appropriateness 
07/05/2025
ALBENDAZOLE 400MG (TAB)
07/05/2025
07/12/2025
TAB
400
Once
Ascariasis
Checking Initial Appropriateness 
07/06/2025
ALBENDAZOLE 400MG (TAB)
07/06/2025
07/08/2025
PO
400 Mg/tab
OD
Ascariasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: